Christopher Lay, CEO of Marsh McLennan UK, William Thomas-Ferrand and Matthew Latham explain why they are backing the London Market Group’s captive initiative.
Luke is joined by new captive owner Mario Ramirez, of Exolum and Zurich's Adriana Scherzinger and Anna-Marie Jarvis to discuss developments in Spain's captive market.
In this GCP Short, Richard is joined by Nicola Fordham and Dr Leena Johns, of MAXIS GBN, to discuss how data on rising cancer claims can inform programme design, treatment choice and preventative measures.
